Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

SHOULDER INNOVATIONS, INC. (SI) Guidance & Earnings Results

On 2026-08-06 SHOULDER INNOVATIONS, INC. raised guidance: "FY2026 revenue guidance raised to $67-69M from…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

SISHOULDER INNOVATIONS, INC.Follow SI — free
Medical Instruments & Supplies · Healthcare
—
Price chart with a free account
Market cap
409.3M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days

What management guided

each earnings 8-K · figures checked against the filing text
ReleaseDirectionWhat they said
6 Aug 26RaisedFY2026 revenue guidance raised to $67-69M from $65-68M · full year
13 May 26RaisedFY26 revenue raised to $65-68M from $62-65M; representing 37-44% YoY growth vs prior 31-37% · full year
10 Mar 26RaisedFY2026 net revenue guidance $62-65M, representing 31-37% growth over FY2025 net revenue of $47.3M · full year
12 Nov 25RaisedFY2025 revenue raised to $45-46M from $42-44M; growth ~42-45% vs prior 33-39% · full year
9 Sep 25RaisedFY2025 revenue $42-44M, representing 33-39% growth over FY2024 · full year

SHOULDER INNOVATIONS, INC. — questions

What guidance did SHOULDER INNOVATIONS, INC. give?
On 2026-08-06: "FY2026 revenue guidance raised to $67-69M from $65-68M"
When does SHOULDER INNOVATIONS, INC. report earnings?
SHOULDER INNOVATIONS, INC.'s next earnings report is expected on 2026-11-05.

Every figure on this page comes from SHOULDER INNOVATIONS, INC.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.